Published in J Clin Microbiol on February 18, 2009
Serotype replacement in disease after pneumococcal vaccination. Lancet (2011) 7.14
Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med (2010) 3.25
Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerg Infect Dis (2010) 2.48
Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics (2009) 1.47
Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy. J Clin Microbiol (2012) 1.24
Pneumococcal serotypes in children in 4 European countries. Emerg Infect Dis (2010) 1.22
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007). Antimicrob Agents Chemother (2010) 1.15
Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR. Eur J Clin Microbiol Infect Dis (2011) 1.11
Serotype and genotype replacement among macrolide-resistant invasive Pneumococci in adults: mechanisms of resistance and association with different transposons. J Clin Microbiol (2010) 1.09
Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children. BMC Infect Dis (2013) 0.98
Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008). Int J Microbiol (2010) 0.97
Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008. Antimicrob Agents Chemother (2011) 0.95
Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009. BMC Infect Dis (2011) 0.93
Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era. BMC Infect Dis (2015) 0.92
Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar. Clin Vaccine Immunol (2010) 0.92
Clonal spread of levofloxacin-resistant streptococcus pneumoniae invasive isolates in Madrid, Spain, 2007 to 2009. Antimicrob Agents Chemother (2011) 0.91
Epidemiology of Streptococcus pneumoniae serogroup 6 isolates from IPD in children and adults in Germany. PLoS One (2013) 0.91
Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany. Eur J Pediatr (2014) 0.89
Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain. Clin Vaccine Immunol (2013) 0.89
The majority of adult pneumococcal invasive infections in Portugal are still potentially vaccine preventable in spite of significant declines of serotypes 1 and 5. PLoS One (2013) 0.89
Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008. BMC Microbiol (2010) 0.88
Serotypes and susceptibilities of paediatric clinical isolates of Streptococcus pneumoniae in Crete, Greece, before and after the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis (2010) 0.88
Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies. PLoS One (2012) 0.86
Nonoptimal DNA topoisomerases allow maintenance of supercoiling levels and improve fitness of Streptococcus pneumoniae. Antimicrob Agents Chemother (2010) 0.84
Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model. PLoS One (2010) 0.83
Characterization of invasive Pneumococci of serogroup 6 from adults in Barcelona, Spain, in 1994 to 2008. J Clin Microbiol (2011) 0.83
The fluoroquinolone levofloxacin triggers the transcriptional activation of iron transport genes that contribute to cell death in Streptococcus pneumoniae. Antimicrob Agents Chemother (2013) 0.82
Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain. Emerg Infect Dis (2014) 0.82
Fluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006. Antimicrob Agents Chemother (2014) 0.82
Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997-2013). Eur J Clin Microbiol Infect Dis (2014) 0.81
Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology. Eur J Clin Microbiol Infect Dis (2014) 0.81
Cefditoren in upper and lower community-acquired respiratory tract infections. Drug Des Devel Ther (2011) 0.80
Susceptibility of recently collected Spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine. Antimicrob Agents Chemother (2010) 0.80
Are risk factors associated with invasive pneumococcal disease according to different serotypes? Hum Vaccin Immunother (2013) 0.80
Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae isolates from elderly patients with pneumonia and acute exacerbation of chronic obstructive pulmonary disease. Antimicrob Agents Chemother (2011) 0.80
Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines. PLoS One (2014) 0.79
Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune Response. PLoS One (2015) 0.79
Reply to Farkouh RA et al. Comment on "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children". Infect Dis Ther (2015) 0.79
In vitro activity of ceftobiprole and seven other antimicrobial agents against invasive Streptococcus pneumoniae isolates in Spain. Eur J Clin Microbiol Infect Dis (2011) 0.77
Response to Wu et al. - Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong. Hum Vaccin Immunother (2016) 0.77
Serotype 5 pneumococci causing invasive pneumococcal disease outbreaks in Barcelona, Spain (1997 to 2011). J Clin Microbiol (2013) 0.77
Update on the clinical utility and optimal use of cefditoren. Int J Gen Med (2012) 0.76
Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates Causing Invasive and Noninvasive Pneumococcal Diseases in Korea from 2008 to 2014. Biomed Res Int (2016) 0.75
Surveillance of pneumococcal diseases in Central and Eastern Europe. Hum Vaccin Immunother (2016) 0.75
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial. Infect Drug Resist (2010) 0.75
Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in Singapore. Int J Gen Med (2014) 0.75
Serotype Distribution and Antimicrobial Susceptibilities of Invasive Streptococcus pneumoniae Isolates from Adults in Korea from 1997 to 2012. J Korean Med Sci (2016) 0.75
Changes in the pneumococcal disease-related hospitalisations in Spain after the replacement of 7-valent by 13-valent conjugate vaccine. Eur J Clin Microbiol Infect Dis (2016) 0.75
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med (2003) 15.48
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med (2006) 7.68
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis (2007) 6.45
Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis (2008) 4.91
Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis (2005) 4.16
Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J (2007) 3.99
Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis (2005) 3.76
Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis (1991) 3.22
Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis (2008) 3.17
Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J Clin Microbiol (1998) 3.10
Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. MMWR Morb Mortal Wkly Rep (2008) 3.03
Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis (2008) 2.74
Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax (2004) 2.31
Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect (2008) 2.22
Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol (2003) 2.17
Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J (2007) 2.15
Dot blot assay for the serotyping of pneumococci. J Clin Microbiol (1997) 1.84
Increase in incidence of childhood empyema in West Midlands, UK. Lancet (1997) 1.84
Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J Clin Microbiol (2002) 1.65
The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease. Vaccine (2006) 1.55
Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003. Clin Microbiol Infect (2005) 1.54
Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother (2000) 1.48
Pediatric parapneumonic empyema, Spain. Emerg Infect Dis (2008) 1.48
Antimicrobial susceptibility and pneumococcal serotypes. J Antimicrob Chemother (2002) 1.18
Molecular typing of pneumococci causing parapneumonic empyema in Spanish children using multilocus sequence typing directly on pleural fluid samples. Pediatr Infect Dis J (2006) 1.16
Empyema thoracis is still increasing in UK children. BMJ (2006) 0.97
Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005. Epidemiol Infect (2007) 0.97
Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect? Clin Infect Dis (2008) 0.95
Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden. Scand J Infect Dis (2003) 0.94
Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis (1991) 6.69
Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis (1991) 3.22
Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J Clin Microbiol (1998) 3.10
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42
Meningococcal disease in a large urban population (Barcelona, 1987-1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance Group. Arch Intern Med (1999) 2.40
Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens. Antimicrob Agents Chemother (1999) 2.33
Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect (2008) 2.22
[Skin infection by Mycobacterium marinum]. Med Clin (Barc) (1995) 1.94
Diabetes among Mexican Americans in Starr County, Texas. Am J Epidemiol (1983) 1.91
Dot blot assay for the serotyping of pneumococci. J Clin Microbiol (1997) 1.84
Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet (1993) 1.83
Increase in resistance to penicillin in pneumococci in Spain. Lancet (1989) 1.83
Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg). Int J Oral Maxillofac Surg (2007) 1.76
Prevalence of maltose-negative Neisseria meningitidis variants during an epidemic period in Spain. J Clin Microbiol (1982) 1.73
Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J Antimicrob Chemother (2000) 1.72
Identification of atypical strains of Streptococcus pneumoniae by a specific DNA probe. Eur J Clin Microbiol Infect Dis (1990) 1.60
Antimicrobial susceptibility of Streptococcus pneumoniae: serotype distribution of penicillin-resistant strains in Spain. Antimicrob Agents Chemother (1982) 1.56
Criteria for arthroscopic treatment of anterior instability of the shoulder: a prospective study. J Bone Joint Surg Br (2005) 1.51
Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother (2000) 1.48
Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease). Sleep Med (2012) 1.47
Mutations at the asp locus of Drosophila lead to multiple free centrosomes in syncytial embryos, but restrict centrosome duplication in larval neuroblasts. J Cell Sci (1990) 1.46
Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp. J Antimicrob Chemother (2009) 1.38
Optochin-resistant variants of Streptococcus pneumoniae. Diagn Microbiol Infect Dis (1990) 1.36
Carriage of Neisseria meningitidis and Neisseria lactamica in a school population during an epidemic period in Spain. J Hyg (Lond) (1985) 1.33
Etiological misidentification by routine biochemical tests of bacteremia caused by Gordonia terrae infection in the course of an episode of acute cholecystitis. J Clin Microbiol (2006) 1.32
Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model. Antimicrob Agents Chemother (2002) 1.32
Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999. Antimicrob Agents Chemother (2001) 1.22
Functional monopolar spindles caused by mutation in mgr, a cell division gene of Drosophila melanogaster. J Cell Sci (1988) 1.21
Antimicrobial susceptibility and pneumococcal serotypes. J Antimicrob Chemother (2002) 1.18
[Meningococcal meningitis in Spain (1978-1980). II. Serotypes and electrophoretic patterns in polyacrylamide gel]. Rev Sanid Hig Publica (Madr) (1983) 1.15
Is sexual transmission an important pattern for herpes simplex type 2 virus seroconversion in the Spanish general population? J Med Virol (1999) 1.15
Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens. Antimicrob Agents Chemother (1999) 1.14
Generation of medial and lateral dorsal body domains by the pannier gene of Drosophila. Development (2000) 1.12
Relationship between chromosome content and nuclear diameter in early spermatids of Drosophila melanogaster. Genet Res (1989) 1.12
Strategy to control methicillin-resistant Staphylococcus aureus post-operative infection in orthopaedic surgery. Int Orthop (2003) 1.12
Seroprevalence and risk factors of swine influenza in Spain. Vet Microbiol (2010) 1.10
31-year-old woman with an enlarged tender liver. Lancet (1995) 1.10
Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. The Spanish Surveillance Group for Respiratory Pathogens. J Antimicrob Chemother (2000) 1.09
Unusual inheritance of Becker type muscular dystrophy. J Med Genet (1978) 1.09
[Meningococcal meningitis in Spain (1978-1980). I. Epidemiologic studies, serogroups and sensitivity to antimicrobial agents]. Rev Sanid Hig Publica (Madr) (1983) 1.08
Modification of bacteraemia by specific antibodies and relation with mortality in a pneumococcal mouse sepsis model. Clin Exp Immunol (2002) 1.06
Enhanced decrease of blood colony counts by specific anti-pneumococcal antibodies in the presence of sub-inhibitory concentrations of amoxicillin. J Antimicrob Chemother (2001) 1.05
Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae? J Antimicrob Chemother (2008) 1.04
The hedgehog morphogen and gradients of cell affinity in the abdomen of Drosophila. Development (1999) 1.03
Mechanisms of early Drosophila mesoderm formation. Dev Suppl (1992) 1.03
Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol (2002) 1.02
Monitoring bluetongue disease (BTV-1) epidemic in southern Spain during 2007. Prev Vet Med (2010) 1.02
hedgehog and engrailed: pattern formation and polarity in the Drosophila abdomen. Development (1999) 1.01
[Meningococcal meningitis in Spain (1978-1981). III. Susceptibility of the meningococcal strains isolated from patients and carriers to the main agents used in the treatment and chemoprophylaxis of meningococcal infections]. Rev Sanid Hig Publica (Madr) (1984) 1.01
Evolution of ORF5 of Spanish porcine reproductive and respiratory syndrome virus strains from 1991 to 2005. Virus Res (2005) 1.00
Glycosylated hemoglobin determination from capillary blood samples. Utility in an epidemiologic survey of diabetes. Am J Epidemiol (1984) 1.00
In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives. J Antimicrob Chemother (2007) 1.00
Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models. Cancer Gene Ther (2011) 0.99
Biosecurity practices in Spanish pig herds: perceptions of farmers and veterinarians of the most important biosecurity measures. Prev Vet Med (2012) 0.98
Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model. J Infect Dis (2000) 0.97
Influence of Haemophilus influenzae beta-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins. Int J Antimicrob Agents (2007) 0.97
Plants used in Guatemala for the treatment of gastrointestinal disorders. 1. Screening of 84 plants against enterobacteria. J Ethnopharmacol (1990) 0.96
Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain. Clin Microbiol Infect (2013) 0.96
New strategies to overcome antimicrobial resistance in Streptococcus pneumoniae with beta-lactam antibiotics. J Antimicrob Chemother (2002) 0.96
Mansonella perstans filariasis in a HIV patient: finding in bone marrow. Haematologica (1999) 0.96
Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain. Int J Antimicrob Agents (2003) 0.95
Streptococcus pneumoniae in children in Spain: 1990-1999. Acta Paediatr Suppl (2000) 0.95
Gross genetic dissection and interaction of the chromosomal region 95E;96F of Drosophila melanogaster. Genetics (1989) 0.95
In vitro susceptibility to gemifloxacin and trovafloxacin of Streptococcus pneumoniae strains exhibiting decreased susceptibility to ciprofloxacin. Eur J Clin Microbiol Infect Dis (2000) 0.95
Prevalence of Neisseria meningitidis in family members of patients with meningococcal infection. J Hyg (Lond) (1982) 0.95
Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine (2000) 0.94
In-vitro pharmacodynamic simulation of clavulanic acid concentrations: effect on Staphylococcus aureus and Haemophilus influenzae beta-lactamase activity. J Antimicrob Chemother (1997) 0.93
Possible introduction of bluetongue into the Balearic Islands, Spain, in 2000, via air streams. Vet Rec (2004) 0.93
Hospital infection caused by non-typable Staphylococcus aureus: application of reverse typing. J Hyg (Lond) (1985) 0.92
Effect of clavulanic acid and/or polymorphonuclear neutrophils on amoxicillin bactericidal activity against Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis (1997) 0.92
Docetaxel-induced interstitial pneumonitis following non-small-cell lung cancer treatment. Clin Transl Oncol (2007) 0.92
IgH, TCR-gamma, and TCR-beta gene rearrangement in 80 B- and T-cell non-Hodgkin's lymphomas: study of the association between proliferation and the so-called "aberrant" patterns. Diagn Mol Pathol (2001) 0.92
Comparative development of Taenia solium in experimental models. J Parasitol (1998) 0.91
Simple immunodiffusion test for detecting antibodies against Legionella pneumophila serotype 1. J Clin Microbiol (1982) 0.91
Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens. J Clin Microbiol (1999) 0.91
Odontogenic bacteria in periodontal disease and resistance patterns to common antibiotics used as treatment and prophylaxis in odontology in Spain. Rev Esp Quimioter (2007) 0.91